Oppenheimer & CO Inc Surface Oncology, Inc. Transaction History

Oppenheimer & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.1 $331 - $663	-316 Reduced 2.86%	10,733 $11,000
Q4 2021 Feb 02, 2022	SELL	$4.73 - $7.9 $100,976 - $168,649	-21,348 Reduced 65.89%	11,049 $53,000
Q3 2021 Nov 12, 2021	SELL	$5.16 - $7.98 $12,574 - $19,447	-2,437 Reduced 7.0%	32,397 $245,000
Q2 2021 Aug 03, 2021	BUY	$6.45 - $9.09 $31,411 - $44,268	4,870 Added 16.25%	34,834 $260,000
Q1 2021 May 10, 2021	BUY	$7.25 - $13.82 $217,239 - $414,102	29,964 New	29,964 $234,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.